Thursday, September 19, 2002
NEW YORK (Reuters Health) - At least six people infected with the
West Nile virus in Mississippi and Louisiana developed a polio-like
syndrome with muscle weakness or paralysis in arms or legs, reported
officials at the US Centers for Disease Control and Prevention (CDC) on
Thursday.
The cases occurred in July and August and were sometimes misdiagnosed
as either a stroke or Guillain-Barre syndrome, a temporary inflammation
of the nerves after a viral infection that causes pain and paralysis.
Guillain-Barre syndrome is often treated with intravenous
immunoglobulin, which are infection-fighting antibodies, or
plasmapheresis, a process in which the fluid portion of the blood is
removed and the remaining blood cells are returned to the patient.
"Many patients with West Nile virus infection who develop acute
weakness are diagnosed with Guillain-Barre and receive treatments
including intravenous immune globulin and plasmapheresis, which could
have adverse side effects," said Dr. Jim Sejear, medical
epidemiologist with the CDC, in a telebriefing with reporters Thursday.
"Our study suggests that many of these people may in fact have
an illness similar to acute polio, which is not helped by these
treatments and which could possibly do more harm than good," he
explained.
In areas where West Nile virus transmission is occurring, the CDC
urges doctors to conduct diagnostic tests for the virus in patients with
weakness in the limbs that is painless--particularly if accompanied by
fever and an increase in white blood cells in the cerebrospinal fluid.
"Physicians need to consider and test for West Nile virus and
strongly consider performing tests to differentiate Guillain-Barre
syndrome from the other causes of weakness before initiating
therapy," Sejear said.
Sejear said the six patients are between 46 to 69 years of age and
have been ill for about 45 to 60 days with "very little
improvement." CDC is continuing to follow these patients, he added.
SOURCE: Morbidity and Mortality Weekly Report 2002;51:825-827.